Novartis shells out $8.7 billion to buy AveXis
April 9, 2018Global stocks rally as Trump tweet eases trade war fears
April 9, 2018Novartis bets big on gene therapy with $8.7 billion AveXis deal
at
ZURICH (Reuters) – Novartis is moving further into gene therapy with a $8.7 billion deal for AveXis that gives the Swiss drugmaker a rare-disease treatment seen reaping billions in sales and bolsters its technology base.
Powered by WPeMatico
